RayzeBio

OverviewSuggest Edit

RayzeBio is a company that develops drugs that harness the power of radioisotopes. Radiopharmaceuticals deliver radioisotopes to tumors via the bloodstream emitting alpha particles. It aims to improve cancer patient survival through its radiopharmaceutical platform.
TypePrivate
Founded2020
HQSan Diego, CA, US
Websiterayzebio.com

Recent NewsAll News

Latest Updates

Employees (est.) (Oct 2021)40(+15%)
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

RayzeBio Office Locations

RayzeBio has an office in San Diego
San Diego, CA, US (HQ)
9880 Campus Point Dr #410
Show all (1)

RayzeBio Financials and Metrics

Summary Metrics

Founding Date

2020

RayzeBio total Funding

$45 m

RayzeBio latest funding size

$45 m

Time since last funding

a year ago

RayzeBio investors

RayzeBio's latest funding round in October 2020 was reported to be $45 m. In total, RayzeBio has raised $45 m
Show all financial metrics

RayzeBio Cybersecurity Score

Cybersecurity ratingPremium dataset

A

94/100

SecurityScorecard logo

RayzeBio Online and Social Media Presence

Embed Graph

RayzeBio News and Updates

RayzeBio Launches with $45M Series A

RayzeBio, Inc. announced today a $45M Series A financing to advance the development of its broad pipeline of targeted radiopharmaceuticals. Co-lead investors venBio Partners and Versant Ventures were joined by Samsara BioCapital.

RayzeBio Frequently Asked Questions

  • When was RayzeBio founded?

    RayzeBio was founded in 2020.

  • How many employees does RayzeBio have?

    RayzeBio has 40 employees.

  • Who are RayzeBio competitors?

    Competitors of RayzeBio include Lassen Therapeutics, Cell Vault and Arranta Bio.

  • Where is RayzeBio headquarters?

    RayzeBio headquarters is located at 9880 Campus Point Dr #410, San Diego.

  • Where are RayzeBio offices?

    RayzeBio has an office in San Diego.

  • How many offices does RayzeBio have?

    RayzeBio has 1 office.